drugset / Trial / NCT00210028

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

NCT00210028

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the objective response rate when ZARNESTRA is added to treatment with tamoxifen

Timeline

Start
2003-08
Primary completion
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject tipifarnib Small molecule
Background Tamoxifen Small molecule

Indications